- Reuters•16 hours ago
GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah ...
- GlobeNewswire•18 hours ago
PHILADELPHIA and OXFORD, United Kingdom, Dec. 05, 2016-- Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, today announced that it has initiated a study of its NY‑ ESO SPEAR™ T‑ ...
GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance
GlaxoSmithKline plc (GSK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||37.67 x 500|
|Ask||37.80 x 800|
|Day's Range||37.56 - 37.85|
|52 Week Range||37.36 - 45.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||244.61|
|Dividend & Yield||1.86 (4.93%)|
|1y Target Est||N/A|